News | February 18, 2022
Bayer raises peak sales for Nubeqa to exceed €3 billion
Darolutamide is developed jointly by Bayer and Orion Corporation
Darolutamide is developed jointly by Bayer and Orion Corporation
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Nirsevimab is the first investigational long-acting antibody designed to protect all infants for the respiratory syncytial virus season with a single dose
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Key takeaways of recent quarter & conference call highlights
GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
Subscribe To Our Newsletter & Stay Updated
